Precision Medicine Hero/ Pharmacist Entrepreneurs Network

?? PGx in Practice: Reducing Liability, Elevating Care ??? Discover how pharmacists can partner with healthcare providers to interpret PGx results, prevent adverse drug reactions, and optimize treatments. Learn why precision medicine is the key to safer, more personalized care—and how it’s setting a new standard in healthcare excellence.? #PrecisionMedicine #PGxLeadership #PharmacyImpact

?? What do you think is the #1 reason patients struggle with medication adherence?**? Medication non-adherence is a significant issue impacting patient outcomes and healthcare costs. As pharmacists, understanding these challenges helps us develop better solutions.? ??? Cast your vote below:?? 1?? **Side effects from medications**?? 2?? **Cost of medications**?? 3?? **Complexity of the regimen (too many meds or doses)**?? 4?? **Lack of understanding about the importance of the medication**? ?? Drop your thoughts or personal experiences in the comments—how do you see precision medicine addressing these barriers?? This poll not only encourages engagement but also creates an opportunity for you to highlight how PGx and the PMH course can help address these challenges through personalized medicine.

"?? Bridging the Gap in Health Equity with PGx ?? Could pharmacogenomics help close healthcare disparities in your pharmacy? This week’s PGx Industry Pulse dives into how PGx testing can bring safer, more effective treatments to underserved populations—transforming lives through personalized care. Discover the impact, study insights, and how you can lead the change in your community. ?? ?? Read the latest issue and join us in making precision medicine accessible for all! #Pharmacogenomics #HealthEquity #PrecisionMedicine #AmbulatoryCare #PMHCommunity #PharmacyPractice

Unlocking Better Chronic Disease Management with PGx in Pharmacy Managing chronic conditions like hypertension and diabetes often means navigating complex treatment protocols that don’t work the same for everyone. But with pharmacogenomics (PGx), pharmacists are transforming patient care by tailoring medications to each individual’s genetic profile. ? The Challenge: Traditional protocols can lead to poor adherence, side effects, and uncontrolled symptoms. ? The Solution: PGx testing helps us select the most effective medications and doses for each patient. ? The Outcome: Real success stories, like Sarah's, show how PGx can turn frustration into improved health outcomes. ?? Curious how PGx can make a difference in your ambulatory care setting? Join our webinar https://lnkd.in/eKWjihYD or book a 1:1 consult with Dr. Melissa Smith to learn more about the path to personalized, effective care for chronic diseases. https://lnkd.in/eE4F-xvx #PrecisionMedicine #PGx #ChronicDiseaseManagement #PharmacyLeadership #PatientCare#AmbulatoryCare

Why Consultant Pharmacists Should Champion PGx in Long-Term Care Polypharmacy—defined as five or more medications per patient—is common in long-term care (LTC) but comes with serious risks, including adverse drug reactions (ADRs) and avoidable hospitalizations. In fact, ADRs are responsible for nearly 30% of LTC hospital admissions each year, impacting the lives of 350,000+ residents. Pharmacogenomics (PGx) offers a powerful solution. By tailoring medication regimens based on residents' genetics, consultant pharmacists can guide safer, more effective medication use and help reduce med-pass times, which improves compliance during board surveys. This approach not only optimizes patient outcomes but also supports facility operations, reducing the risk of regulatory citations. Let’s lead the charge in bringing precision medicine to LTC! For those interested in integrating PGx into their practice, join our next **Precision Medicine Hero** webinar https://lnkd.in/eKWjihYD or book a 1:1 call to explore how PGx can transform care. https://lnkd.in/eE4F-xvx #PrecisionMedicine #Pharmacogenomics #ConsultantPharmacy #LongTermCare #PharmacyLeadership #Deprescribing

?? We Want Your Insight! Is deprescribing an area pharmacists should take the lead on in LTC facilities when implementing PGx Testing? As the population ages, managing medications for elderly patients in long-term care (LTC) becomes increasingly complex. **Deprescribing**—the process of tapering or stopping medications—can significantly improve patient outcomes, reduce adverse drug events, and enhance overall quality of life. Pharmacists, with their expertise in medication management, are uniquely positioned to spearhead these initiatives. Why Your Opinion Matters: - Patient Safety: Reducing polypharmacy can decrease the risk of harmful drug interactions and side effects. - Cost Efficiency: Optimizing medication regimens can lead to substantial healthcare savings. - Enhanced Quality of Life: Tailored medication plans can improve cognitive and functional outcomes for residents. ?? Participate in our poll and share your thoughts! Poll Question:? Is deprescribing an area pharmacists should take the lead on in LTC facilities when implementing PGx Testing?* Options: 1. Yes, absolutely – pharmacists are best equipped for this role 2. Possibly, with the right support and resources 3. No, it should be a collaborative effort with other providers 4. Not sure – need more information on deprescribing benefits ?? Your feedback will help shape the future of pharmacogenomics in long-term care. Let’s work together to enhance patient safety and care quality! #Pharmacogenomics #Deprescribing #LongTermCare #ConsultantPharmacist #ElderCare #MedicationManagement #PatientSafety #HealthcareInnovation #Polypharmacy #SeniorHealth

?? Polypharmacy is a silent risk for elderly patients. Could PGx be the answer to safer medication plans? With almost half of long-term care residents taking nine or more medications daily, the potential for adverse drug events (ADEs) is significant. Pharmacogenomic (PGx) testing could be a game-changer in addressing these risks. Here’s how: - Reduction in Adverse Drug Events (ADEs): PGx testing can reduce ADEs by 20-30% among the elderly by identifying and adjusting medications based on genetic compatibility. https://lnkd.in/eRsgcHkY ?? - Decrease in Hospitalizations and ER Visits: Geriatric patients who underwent PGx testing experienced a 39% drop in hospitalizations and a 71% reduction in emergency visits due to optimized medication regimens. https://lnkd.in/ek85kkgp For LTC consultant pharmacists, now is the time to explore PGx. Enhance your skill set, champion safe medication use, and improve patient outcomes within your facilities. ?? Enroll in 101 Ways Pharmacists Can Bring Precision Medicine to Their Community. https://lnkd.in/eKWjihYD Book a 1:1 Call with Melissa Smith PharmD, CPH to discuss your options https://lnkd.in/eE4F-xvx #Pharmacogenomics #Polypharmacy #LongTermCare #ConsultantPharmacist #PatientSafety #ElderCare #MedicationManagement

Breaking Barriers in Pharmacogenomics for Oncology! A recent survey from the Journal of Oncology Pharmacy Practice uncovers key challenges oncology pharmacists face when adopting pharmacogenomics (PGx) in clinical care. Link to article abstract below: https://lnkd.in/gJS5_M2X While most pharmacists are comfortable with PGx data, poor visibility in electronic medical records (EMRs), lack of resources, and insurance barriers prevent effective implementation. Survey findings show that pharmacists with PGY-2 training, tumor board involvement, and roles in local PGx policy development feel more confident navigating these hurdles. ?? Swipe through for the full insights, and join our upcoming webinar 101 Ways Pharmacists Can Bring Precision Medicine to Their Community https://lnkd.in/eKWjihYD or book a call with Dr. Melissa Smith to discuss how PGx can elevate your practice! https://lnkd.in/eE4F-xvx #OncologyPharmacy #Pharmacogenomics #PrecisionMedicine #CancerCare #PharmacyPractice #PGx #Oncology #HealthcareInnovation #PharmacyLeadership

?? The Scariest Risk You Don’t See: Not Knowing Your DPYD Phenotype Before Capecitabine Treatment! ?? This Halloween, let’s talk about a fright that’s all too real: taking Capecitabine (a common chemotherapy drug for breast cancer) without knowing if your body can safely process it. ???? Capecitabine relies on an enzyme called DPD, which is encoded by the DPYD gene. But here’s the scary truth: not everyone’s DPYD phenotype allows their body to break down this medication properly. For patients with a *DPYD* deficiency, Capecitabine can lead to severe, even life-threatening toxicity. ?? ?? That’s where pharmacogenomics steps in. With a simple genetic test, patients can find out their DPYD status—before they start treatment. This knowledge can help doctors choose the right dose or even recommend alternative therapies, reducing risk and enhancing safety. This Halloween, let’s turn fear into action. Knowing your genes isn’t just empowering—it can be lifesaving. ????? #BreastCancerAwareness #Pharmacogenomics #DPYD #Capecitabine #PrecisionMedicineHero #Halloween

?? Weekly PGx Industry Pulse: Which Breast Cancer Medications Are Impacted by PGx? This week’s edition dives into the crucial role of pharmacogenomics in breast cancer treatment. Discover how medications like Tamoxifen, Capecitabine, and Anastrozole are impacted by genetics—and why early PGx testing is key to safer, more effective care. In this issue: - Real-world patient story highlighting the importance of DPYD testing before capecitabine - Key genes like CYP2D6 and CYP19A1 that guide personalized treatment - How PGx insights help reduce adverse events and optimize therapy ?? Stay informed on the latest in PGx and see how personalized medicine is shaping cancer care. #Pharmacogenomics #BreastCancerAwareness #PrecisionMedicine #PGxIndustryPulse